JPWO2019177997A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019177997A5 JPWO2019177997A5 JP2020547384A JP2020547384A JPWO2019177997A5 JP WO2019177997 A5 JPWO2019177997 A5 JP WO2019177997A5 JP 2020547384 A JP2020547384 A JP 2020547384A JP 2020547384 A JP2020547384 A JP 2020547384A JP WO2019177997 A5 JPWO2019177997 A5 JP WO2019177997A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- biphenyl
- diazaspiro
- heptane
- methylsulfonyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 2'-Ethyl-4'-((4- (Methylsulfonyl) piperidine-1-yl) methyl)-[1,1'-biphenyl] -4-yl Chemical group 0.000 claims 53
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 20
- 150000003839 salts Chemical class 0.000 claims 16
- 239000011780 sodium chloride Substances 0.000 claims 16
- 150000001875 compounds Chemical class 0.000 claims 15
- 239000012453 solvate Substances 0.000 claims 15
- 125000000217 alkyl group Chemical group 0.000 claims 13
- 235000010290 biphenyl Nutrition 0.000 claims 11
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical group C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims 11
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims 11
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 9
- 125000001072 heteroaryl group Chemical group 0.000 claims 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N iso-propanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 8
- 125000001475 halogen functional group Chemical group 0.000 claims 7
- 229910052739 hydrogen Inorganic materials 0.000 claims 5
- 239000001257 hydrogen Substances 0.000 claims 5
- 125000000623 heterocyclic group Chemical group 0.000 claims 4
- 150000002431 hydrogen Chemical class 0.000 claims 4
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 3
- FSSPGSAQUIYDCN-UHFFFAOYSA-N 1,3-Propane sultone Chemical compound O=S1(=O)CCCO1 FSSPGSAQUIYDCN-UHFFFAOYSA-N 0.000 claims 3
- 125000003545 alkoxy group Chemical group 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 125000006727 (C1-C6) alkenyl group Chemical group 0.000 claims 2
- 125000006693 (C2-C9) heterocyclyl group Chemical group 0.000 claims 2
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims 2
- FPQQSNUTBWFFLB-UHFFFAOYSA-N 2-chloro-N-(2,6-dimethylphenyl)acetamide Chemical compound CC1=CC=CC(C)=C1NC(=O)CCl FPQQSNUTBWFFLB-UHFFFAOYSA-N 0.000 claims 2
- NKBWMBRPILTCRD-UHFFFAOYSA-M 2-methylheptanoate Chemical compound CCCCCC(C)C([O-])=O NKBWMBRPILTCRD-UHFFFAOYSA-M 0.000 claims 2
- 206010021972 Inflammatory bowel disease Diseases 0.000 claims 2
- 208000008589 Obesity Diseases 0.000 claims 2
- IKHGUXGNUITLKF-UHFFFAOYSA-N acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 125000004432 carbon atoms Chemical group C* 0.000 claims 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 235000020824 obesity Nutrition 0.000 claims 2
- 201000002661 spondylitis Diseases 0.000 claims 2
- 201000010874 syndrome Diseases 0.000 claims 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 2
- DYWSVUBJGFTOQC-UHFFFAOYSA-M 2-ethylheptanoate Chemical compound CCCCCC(CC)C([O-])=O DYWSVUBJGFTOQC-UHFFFAOYSA-M 0.000 claims 1
- 206010003210 Arteriosclerosis Diseases 0.000 claims 1
- 206010003246 Arthritis Diseases 0.000 claims 1
- 206010003267 Arthritis reactive Diseases 0.000 claims 1
- 208000006673 Asthma Diseases 0.000 claims 1
- TVWGEGREAXSCRP-UHFFFAOYSA-N C(C)C1=C(C(=CC(=C1F)CN1CC2(C1)CN(C2)S(=O)(=O)C)F)C1=C(C=C(C=C1)C(C(F)(F)F)(C(F)(F)F)O)C Chemical compound C(C)C1=C(C(=CC(=C1F)CN1CC2(C1)CN(C2)S(=O)(=O)C)F)C1=C(C=C(C=C1)C(C(F)(F)F)(C(F)(F)F)O)C TVWGEGREAXSCRP-UHFFFAOYSA-N 0.000 claims 1
- FSKBAUUULYQFCG-UHFFFAOYSA-N C(C)C1=C(C(=CC(=C1F)CN1CC2(C1)CN(C2)S(=O)(=O)C)F)C1=C(C=C(C=C1)C(C(F)(F)F)(C(F)(F)F)O)F Chemical compound C(C)C1=C(C(=CC(=C1F)CN1CC2(C1)CN(C2)S(=O)(=O)C)F)C1=C(C=C(C=C1)C(C(F)(F)F)(C(F)(F)F)O)F FSKBAUUULYQFCG-UHFFFAOYSA-N 0.000 claims 1
- KIODPCKTNMINIP-UHFFFAOYSA-N C(C)C1=C(C(=CC(=C1F)CN1CC2(C1)CN(C2)S(=O)(=O)C)F)C1=CC=C(C=C1)C(C(F)(F)F)(C(F)(F)F)O Chemical compound C(C)C1=C(C(=CC(=C1F)CN1CC2(C1)CN(C2)S(=O)(=O)C)F)C1=CC=C(C=C1)C(C(F)(F)F)(C(F)(F)F)O KIODPCKTNMINIP-UHFFFAOYSA-N 0.000 claims 1
- NVKAVTOKHZNYQA-UHFFFAOYSA-N C(C)C1=C(C=C(C(=C1)CN1CC2(C1)CN(C2)S(=O)(=O)C)F)C1=C(C=C(C=C1)C(C(F)(F)F)(C(F)(F)F)O)F Chemical compound C(C)C1=C(C=C(C(=C1)CN1CC2(C1)CN(C2)S(=O)(=O)C)F)C1=C(C=C(C=C1)C(C(F)(F)F)(C(F)(F)F)O)F NVKAVTOKHZNYQA-UHFFFAOYSA-N 0.000 claims 1
- YYMGREZOIVOFOD-UHFFFAOYSA-N C(C)C1=C(C=CC(=C1)C(C(F)(F)F)(C(F)(F)F)O)C1=C(C(=C(C=C1F)CN1CC2(C1)CN(C2)S(=O)(=O)C)F)C(C)C Chemical compound C(C)C1=C(C=CC(=C1)C(C(F)(F)F)(C(F)(F)F)O)C1=C(C(=C(C=C1F)CN1CC2(C1)CN(C2)S(=O)(=O)C)F)C(C)C YYMGREZOIVOFOD-UHFFFAOYSA-N 0.000 claims 1
- PEFAVBPKAOJXKT-UHFFFAOYSA-N C(C)C1=C(C=CC(=C1)C(C(F)(F)F)(C(F)(F)F)O)C1=C(C(=C(C=C1F)CN1CC2(C1)CN(C2)S(=O)(=O)C)F)CC Chemical compound C(C)C1=C(C=CC(=C1)C(C(F)(F)F)(C(F)(F)F)O)C1=C(C(=C(C=C1F)CN1CC2(C1)CN(C2)S(=O)(=O)C)F)CC PEFAVBPKAOJXKT-UHFFFAOYSA-N 0.000 claims 1
- IJZFXWPGSMQGSS-UHFFFAOYSA-N C(C)C1=C(C=CC(=C1)CN1CC2(C1)CN(C2)S(=O)(=O)C)C=1C=CC(=NC=1)C(C(F)(F)F)(C(F)(F)F)O Chemical compound C(C)C1=C(C=CC(=C1)CN1CC2(C1)CN(C2)S(=O)(=O)C)C=1C=CC(=NC=1)C(C(F)(F)F)(C(F)(F)F)O IJZFXWPGSMQGSS-UHFFFAOYSA-N 0.000 claims 1
- VVZNBRHWWMYWKB-UHFFFAOYSA-N C(C)C1=C(C=CC(=C1)CN1CCC(CC1)CS(=O)(=O)C)C1=CC=C(C=C1)C(C(F)(F)F)(C(F)(F)F)O Chemical compound C(C)C1=C(C=CC(=C1)CN1CCC(CC1)CS(=O)(=O)C)C1=CC=C(C=C1)C(C(F)(F)F)(C(F)(F)F)O VVZNBRHWWMYWKB-UHFFFAOYSA-N 0.000 claims 1
- ULBRQQFAPPZTFM-UHFFFAOYSA-N C(C)C1=C(C=NC(=C1)CN1CC2(C1)CN(C2)S(=O)(=O)C)C1=C(C=C(C=C1)C(C(F)(F)F)(C(F)(F)F)O)C Chemical compound C(C)C1=C(C=NC(=C1)CN1CC2(C1)CN(C2)S(=O)(=O)C)C1=C(C=C(C=C1)C(C(F)(F)F)(C(F)(F)F)O)C ULBRQQFAPPZTFM-UHFFFAOYSA-N 0.000 claims 1
- FXBJLXCQDWSHDE-UHFFFAOYSA-N C(C)C1=C(C=NC(=C1)CN1CC2(C1)CN(C2)S(=O)(=O)C)C1=CC=C(C=C1)C(C(F)(F)F)(C(F)(F)F)O Chemical compound C(C)C1=C(C=NC(=C1)CN1CC2(C1)CN(C2)S(=O)(=O)C)C1=CC=C(C=C1)C(C(F)(F)F)(C(F)(F)F)O FXBJLXCQDWSHDE-UHFFFAOYSA-N 0.000 claims 1
- OANYEDJRGLVTHA-UHFFFAOYSA-N C(C)C1=NC(=CC=C1C1=C(C=C(C=C1)C(C(F)(F)F)(C(F)(F)F)O)C)CN1CC2(C1)CN(C2)S(=O)(=O)C Chemical compound C(C)C1=NC(=CC=C1C1=C(C=C(C=C1)C(C(F)(F)F)(C(F)(F)F)O)C)CN1CC2(C1)CN(C2)S(=O)(=O)C OANYEDJRGLVTHA-UHFFFAOYSA-N 0.000 claims 1
- WWFUKBWYXJZUHC-UHFFFAOYSA-N C(C)C=1C(=NC=C(C=1)CN1CC2(C1)CN(C2)S(=O)(=O)C)C1=CC=C(C=C1)C(C(F)(F)F)(C(F)(F)F)O Chemical compound C(C)C=1C(=NC=C(C=1)CN1CC2(C1)CN(C2)S(=O)(=O)C)C1=CC=C(C=C1)C(C(F)(F)F)(C(F)(F)F)O WWFUKBWYXJZUHC-UHFFFAOYSA-N 0.000 claims 1
- CXDHCFCBVUZADM-UHFFFAOYSA-N C1(CC1)C1=C(C(=CC(=C1F)CN1CC2(C1)CN(C2)S(=O)(=O)C)F)C1=C(C=C(C=C1)C(C(F)(F)F)(C(F)(F)F)O)F Chemical compound C1(CC1)C1=C(C(=CC(=C1F)CN1CC2(C1)CN(C2)S(=O)(=O)C)F)C1=C(C=C(C=C1)C(C(F)(F)F)(C(F)(F)F)O)F CXDHCFCBVUZADM-UHFFFAOYSA-N 0.000 claims 1
- ZRYDBVLWYWRLOT-UHFFFAOYSA-N C1(CC1)C1=C(C(=CC(=C1F)CN1CC2(C1)CN(C2)S(=O)(=O)C)F)C1=CC=C(C=C1)C(C(F)(F)F)(C(F)(F)F)O Chemical compound C1(CC1)C1=C(C(=CC(=C1F)CN1CC2(C1)CN(C2)S(=O)(=O)C)F)C1=CC=C(C=C1)C(C(F)(F)F)(C(F)(F)F)O ZRYDBVLWYWRLOT-UHFFFAOYSA-N 0.000 claims 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- JTBNOGYLPRAOKU-UHFFFAOYSA-N ClC1=C(C=CC(=C1)C(C(F)(F)F)(C(F)(F)F)O)C1=C(C(=C(C=C1F)CN1CC2(C1)CN(C2)S(=O)(=O)C)F)C(C)C Chemical compound ClC1=C(C=CC(=C1)C(C(F)(F)F)(C(F)(F)F)O)C1=C(C(=C(C=C1F)CN1CC2(C1)CN(C2)S(=O)(=O)C)F)C(C)C JTBNOGYLPRAOKU-UHFFFAOYSA-N 0.000 claims 1
- DWOUIKLEPUUYON-UHFFFAOYSA-N ClC1=C(C=CC(=C1)C(C(F)(F)F)(C(F)(F)F)O)C1=C(C(=C(C=C1F)CN1CC2(C1)CN(C2)S(=O)(=O)C)F)CC Chemical compound ClC1=C(C=CC(=C1)C(C(F)(F)F)(C(F)(F)F)O)C1=C(C(=C(C=C1F)CN1CC2(C1)CN(C2)S(=O)(=O)C)F)CC DWOUIKLEPUUYON-UHFFFAOYSA-N 0.000 claims 1
- DHEVOCTZCSFVCN-UHFFFAOYSA-N ClC1=C(C=CC(=C1)C(C(F)(F)F)(C(F)(F)F)O)C1=C(C=C(C(=C1)F)CN1CC2(C1)CN(C2)S(=O)(=O)C)C(C)C Chemical compound ClC1=C(C=CC(=C1)C(C(F)(F)F)(C(F)(F)F)O)C1=C(C=C(C(=C1)F)CN1CC2(C1)CN(C2)S(=O)(=O)C)C(C)C DHEVOCTZCSFVCN-UHFFFAOYSA-N 0.000 claims 1
- VEYZALVNTPRIPW-UHFFFAOYSA-N ClC1=C(C=CC(=C1)C(C(F)(F)F)(C(F)(F)F)O)C1=C(C=C(C(=C1)F)CN1CC2(C1)CN(C2)S(=O)(=O)C)CC Chemical compound ClC1=C(C=CC(=C1)C(C(F)(F)F)(C(F)(F)F)O)C1=C(C=C(C(=C1)F)CN1CC2(C1)CN(C2)S(=O)(=O)C)CC VEYZALVNTPRIPW-UHFFFAOYSA-N 0.000 claims 1
- 206010009900 Colitis ulcerative Diseases 0.000 claims 1
- 206010011401 Crohn's disease Diseases 0.000 claims 1
- 206010012438 Dermatitis atopic Diseases 0.000 claims 1
- 206010012441 Dermatitis bullous Diseases 0.000 claims 1
- 206010012601 Diabetes mellitus Diseases 0.000 claims 1
- RGLYKWWBQGJZGM-ISLYRVAYSA-N Diethylstilbestrol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(\CC)C1=CC=C(O)C=C1 RGLYKWWBQGJZGM-ISLYRVAYSA-N 0.000 claims 1
- OEHFRZLKGRKFAS-UHFFFAOYSA-N Droxicam Chemical compound C12=CC=CC=C2S(=O)(=O)N(C)C(C2=O)=C1OC(=O)N2C1=CC=CC=N1 OEHFRZLKGRKFAS-UHFFFAOYSA-N 0.000 claims 1
- 208000004232 Enteritis Diseases 0.000 claims 1
- CRXZRWMBMNJXMJ-UHFFFAOYSA-N FC(C(C(F)(F)F)(O)C1=CC=C(C=C1)C1=C(C=C(C=C1)CN1CC2(C1)CN(C2)S(=O)(=O)C)C(F)(F)F)(F)F Chemical compound FC(C(C(F)(F)F)(O)C1=CC=C(C=C1)C1=C(C=C(C=C1)CN1CC2(C1)CN(C2)S(=O)(=O)C)C(F)(F)F)(F)F CRXZRWMBMNJXMJ-UHFFFAOYSA-N 0.000 claims 1
- FFHQSJLWKXEQOU-UHFFFAOYSA-N FC1=C(C(=CC(=C1F)CN1CC2(C1)CN(C2)S(=O)(=O)C)C(C)C)C1=CC=C(C=C1)C(C(F)(F)F)(C(F)(F)F)O Chemical compound FC1=C(C(=CC(=C1F)CN1CC2(C1)CN(C2)S(=O)(=O)C)C(C)C)C1=CC=C(C=C1)C(C(F)(F)F)(C(F)(F)F)O FFHQSJLWKXEQOU-UHFFFAOYSA-N 0.000 claims 1
- CIILKARKVJFMHV-UHFFFAOYSA-N FC1=C(C=CC(=C1)C(C(F)(F)F)(C(F)(F)F)O)C1=C(C=C(C(=C1)F)CN1CC2(C1)CN(C2)S(=O)(=O)C)C(C)C Chemical compound FC1=C(C=CC(=C1)C(C(F)(F)F)(C(F)(F)F)O)C1=C(C=C(C(=C1)F)CN1CC2(C1)CN(C2)S(=O)(=O)C)C(C)C CIILKARKVJFMHV-UHFFFAOYSA-N 0.000 claims 1
- MWGHOBGVXLJQQX-UHFFFAOYSA-N FC=1C(=C(C(=CC=1CN1CC2(C1)CN(C2)S(=O)(=O)C)F)C1=C(C=C(C=C1)C(C(F)(F)F)(C(F)(F)F)O)C)C(C)C Chemical compound FC=1C(=C(C(=CC=1CN1CC2(C1)CN(C2)S(=O)(=O)C)F)C1=C(C=C(C=C1)C(C(F)(F)F)(C(F)(F)F)O)C)C(C)C MWGHOBGVXLJQQX-UHFFFAOYSA-N 0.000 claims 1
- CIPHAHAVHMUKEH-UHFFFAOYSA-N FC=1C(=C(C(=CC=1CN1CC2(C1)CN(C2)S(=O)(=O)C)F)C1=CC=C(C=C1)C(C(F)(F)F)(C(F)(F)F)O)C(C)C Chemical compound FC=1C(=C(C(=CC=1CN1CC2(C1)CN(C2)S(=O)(=O)C)F)C1=CC=C(C=C1)C(C(F)(F)F)(C(F)(F)F)O)C(C)C CIPHAHAVHMUKEH-UHFFFAOYSA-N 0.000 claims 1
- FQCAFDAAESHPIC-UHFFFAOYSA-N FC=1C(=C(C(=CC=1CN1CC2(CN(C2)S(=O)(=O)C)CC1)F)C1=CC=C(C=C1)C(C(F)(F)F)(C(F)(F)F)O)C(C)C Chemical compound FC=1C(=C(C(=CC=1CN1CC2(CN(C2)S(=O)(=O)C)CC1)F)C1=CC=C(C=C1)C(C(F)(F)F)(C(F)(F)F)O)C(C)C FQCAFDAAESHPIC-UHFFFAOYSA-N 0.000 claims 1
- XQVZXUGFFQWFDD-UHFFFAOYSA-N FC=1C(=C(C=C(C=1CN1CC2(C1)CN(C2)S(=O)(=O)C)F)C1=CC=C(C=C1)C(C(F)(F)F)(C(F)(F)F)O)C(C)C Chemical compound FC=1C(=C(C=C(C=1CN1CC2(C1)CN(C2)S(=O)(=O)C)F)C1=CC=C(C=C1)C(C(F)(F)F)(C(F)(F)F)O)C(C)C XQVZXUGFFQWFDD-UHFFFAOYSA-N 0.000 claims 1
- 206010022489 Insulin resistance Diseases 0.000 claims 1
- 208000003456 Juvenile Arthritis Diseases 0.000 claims 1
- 206010059176 Juvenile idiopathic arthritis Diseases 0.000 claims 1
- 208000002741 Leukoplakia Diseases 0.000 claims 1
- 208000005777 Lupus Nephritis Diseases 0.000 claims 1
- 206010025135 Lupus erythematosus Diseases 0.000 claims 1
- OBLVNNBHKQVVMW-UHFFFAOYSA-N N1=CC=C(C=C1)CN1CC2(C1)CNC2 Chemical compound N1=CC=C(C=C1)CN1CC2(C1)CNC2 OBLVNNBHKQVVMW-UHFFFAOYSA-N 0.000 claims 1
- GYHFUZHODSMOHU-UHFFFAOYSA-N Nonanal Chemical compound CCCCCCCCC=O GYHFUZHODSMOHU-UHFFFAOYSA-N 0.000 claims 1
- 206010037162 Psoriatic arthropathy Diseases 0.000 claims 1
- 208000002574 Reactive Arthritis Diseases 0.000 claims 1
- 206010039073 Rheumatoid arthritis Diseases 0.000 claims 1
- 206010039085 Rhinitis allergic Diseases 0.000 claims 1
- 210000004243 Sweat Anatomy 0.000 claims 1
- 206010071575 Undifferentiated connective tissue disease Diseases 0.000 claims 1
- 206010047115 Vasculitis Diseases 0.000 claims 1
- 201000010105 allergic rhinitis Diseases 0.000 claims 1
- 201000001320 atherosclerosis Diseases 0.000 claims 1
- 201000008937 atopic dermatitis Diseases 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 201000002215 juvenile rheumatoid arthritis Diseases 0.000 claims 1
- 201000003265 lymphadenitis Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- IYTXKIXETAELAV-UHFFFAOYSA-N nonan-3-one Chemical compound CCCCCCC(=O)CC IYTXKIXETAELAV-UHFFFAOYSA-N 0.000 claims 1
- 125000004043 oxo group Chemical group O=* 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 201000004681 psoriasis Diseases 0.000 claims 1
- 201000001263 psoriatic arthritis Diseases 0.000 claims 1
- 230000001256 tonic Effects 0.000 claims 1
- 201000006704 ulcerative colitis Diseases 0.000 claims 1
Claims (15)
式中、
Zは-(C(R6)(R7))t-であり、
R1とR2は(i)と(ii)から選択され、
(i)R1とR2は、それらが結合している炭素原子と一体となって、4、5、または6員のヘテロシクリル環を形成し、ここで、4、5、または6員のヘテロシクリル環は、1~4のR3a基で随意に置換され、ならびに、
(ii)R1は水素であり、および、R2は、-S(O)2R10、-C1-C6アルキル-S(O)2R10、-N(R11)S(O)2R10、または-C1-C6アルキル-N(R11)S(O)2R10であり、
R3はそれぞれ独立して、ハロおよびC1-C6アルキルから選択され、
R3aはそれぞれ独立して、C1-C6アルキル、C1-C6ハロアルキル、C2-C9ヘテロアリール、(C2-C9ヘテロアリール)-C1-C6アルキレン-、オキソ、-S(O)2R10、-C(O)R10、-C(O)OR11、および-C(O)N(R11)2から選択され、ここで、C2-C9ヘテロアリールおよび(C2-C9ヘテロアリール)-C1-C6アルキレン-は、ハロ、C1-C6アルキル、C1-C6ハロアルキル、およびヒドロキシルから独立して選択された1~3つの基で随意に置換され、
各R4と各R5はそれぞれ独立して、ハロ、シアノ、-OH、C1-C6アルキル、C1-C6アルケニル、C1-C6ハロアルキル、C1-C6アルコキシ、C3-C8シクロアルキル、-N(R9)2、-C(O)R8、-C(O)OR9、-C(O)N(R9)2、-N(R9)C(O)R8、-N(R9)SO2R8、-SO2R8、および-SO2N(R8)2から選択され、
各R6と各R7はそれぞれ独立して、水素、ハロ、またはC1-C6アルキルであり、
R8はそれぞれ独立して、C1-C6アルキルまたはC1-C6ハロアルキルであり、
R9はそれぞれ独立して、水素、C1-C6アルキル、またはC1-C6ハロアルキルであり、
R10はそれぞれ独立して、C1-C6アルキル、C1-C6ハロアルキル、C1-C6アルキル-O-C1-C6アルキル-、C3-C8シクロアルキル、C2-C9ヘテロシクリル、フェニル、(フェニル)-C1-C6アルキレン-、C2-C9ヘテロアリール、または(C2-C9ヘテロアリール)-C1-C6アルキレン-であり、ここで、C3-C8シクロアルキル、C2-C9ヘテロシクリル、フェニル、(フェニル)-C1-C6アルキレン-、C2-C9ヘテロアリール、または(C2-C9ヘテロアリール)-C1-C6アルキレン-は、ハロ、C1-C6アルキル、C1-C6ハロアルキル、およびヒドロキシルから選択された1~3つの基で随意に置換され、
R11はそれぞれ独立して、水素、C1-C6アルキル、またはC1-C6ハロアルキルであり、
mは1、2、または3であり、
nは1、2、または3であり、
kは0、1、2、3、または4であり、
pは0、1、2、3、または4であり、
qは0、1、2、3、または4であり、および、
tは0、1、2、または3である、
化合物、あるいはその薬学的に許容可能な塩、溶媒和物、または立体異性体。 A compound having the formula (I),
During the ceremony
Z is-(C (R 6 ) (R 7 )) t- ,
R 1 and R 2 are selected from (i) and (ii).
(I) R 1 and R 2 together with the carbon atom to which they are bonded form a 4, 5, or 6-membered heterocyclyl ring, where the 4, 5, or 6-membered heterocyclyl. Rings are optionally substituted with 1-4 R3a groups, as well as
(Ii) R 1 is hydrogen, and R 2 is -S (O) 2 R 10 , -C 1 -C 6 alkyl-S (O) 2 R 10 , -N (R 11 ) S (O). ) 2 R 10 or -C 1 -C 6 alkyl-N (R 11 ) S (O) 2 R 10
R3 is independently selected from halo and C1 - C6 alkyl, respectively .
R 3a are independently C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 2 -C 9 heteroaryl, (C 2 -C 9 heteroaryl) -C 1 -C 6 alkylene-, oxo, respectively. -S (O) 2 R 10 , -C (O) R 10 , -C (O) OR 11 and -C (O) N (R 11 ) 2 are selected, where C 2 -C 9 hetero Aryl and (C 2 -C 9 heteroaryl) -C 1 -C 6 alkylene- are selected independently of halo, C 1 -C 6 alkyl, C 1 -C 6 halo alkyl, and hydroxyl. Replaced arbitrarily by the group,
Each R 4 and each R 5 are independently halo, cyano, -OH, C 1 -C 6 alkyl, C 1 -C 6 alkenyl, C 1 -C 6 halo alkyl, C 1 -C 6 alkoxy, C 3 -C 8 cycloalkyl, -N (R 9 ) 2 , -C (O) R 8 , -C (O) OR 9 , -C (O) N (R 9 ) 2 , -N (R 9 ) C ( O) R 8 , -N (R 9 ) SO 2 R 8 , -SO 2 R 8 , and -SO 2 N (R 8 ) 2 selected from
Each R 6 and each R 7 are independently hydrogen, halo, or C1 -C 6 alkyl .
R 8 are independently C1-C 6 alkyl or C 1 - C 6 haloalkyl, respectively.
R 9 are independently hydrogen, C1-C 6 alkyl, or C 1 - C 6 haloalkyl, respectively.
R 10 are independently C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 alkyl-OC 1 -C 6 alkyl-, C 3 -C 8 cycloalkyl, C 2- C 9 heterocyclyl, phenyl, (phenyl) -C 1 -C 6 alkylene-, C 2 -C 9 heteroaryl, or (C 2 -C 9 heteroaryl) -C 1 -C 6 alkylene-, where C 3 -C 8 cycloalkyl, C 2 -C 9 heterocyclyl, phenyl, (phenyl) -C 1 -C 6 alkylene-, C 2 -C 9 heteroaryl, or (C 2 -C 9 heteroaryl) -C 1 -C 6 alkylene- is optionally substituted with 1-3 groups selected from halo, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, and hydroxyl.
R 11 are independently hydrogen, C1-C 6 alkyl, or C 1 - C 6 haloalkyl, respectively.
m is 1, 2, or 3
n is 1, 2, or 3
k is 0, 1, 2, 3, or 4,
p is 0, 1, 2, 3, or 4,
q is 0, 1, 2, 3, or 4, and
t is 0, 1, 2, or 3,
A compound, or a pharmaceutically acceptable salt, solvate, or stereoisomer thereof.
式中、During the ceremony
Xは、-O-、-NH-、-N(RX is -O-, -NH-, -N (R) 3a3a )-、-S-、-S(O)-、または-S(O))-, -S-, -S (O)-, or -S (O) 22 -であり、-And
aは1または2であり、および、a is 1 or 2 and
bは1または2である、請求項4に記載の化合物、あるいはその薬学的に許容可能な塩、溶媒和物、または立体異性体。b is 1 or 2, the compound of claim 4, or a pharmaceutically acceptable salt, solvate, or stereoisomer thereof.
2-(2’-エチル-4’-((4-(メチルスルホニル)ピペリジン-1-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2'-Ethyl-4'-((4- (Methylsulfonyl) piperidine-1-yl) methyl)-[1,1'-biphenyl] -4-yl) -1,1,1,3 3,3-Hexafluoropropane-2-ol,
N-((1-((2-エチル-4’-(1,1,1,3,3,3-ヘキサフルオロ-2-ヒドロキシプロパン-2-イル)-[1,1’-ビフェニル]-4-イル)メチル)アゼチジン-3-イル)メチル)-N-メチルメタンスルホンアミド、 N-((1-((2-ethyl-4'-(1,1,1,3,3,3-hexafluoro-2-hydroxypropane-2-yl)-[1,1'-biphenyl]- 4-Il) Methyl) Azetidine-3-yl) Methyl) -N-Methylmethane sulfonamide,
N-((1-((2-エチル-4’-(1,1,1,3,3,3-ヘキサフルオロ-2-ヒドロキシプロパン-2-イル)-[1,1’-ビフェニル]-4-イル)メチル)アゼチジン-3-イル)メチル)メタンスルホンアミド、 N-((1-((2-ethyl-4'-(1,1,1,3,3,3-hexafluoro-2-hydroxypropane-2-yl)-[1,1'-biphenyl]- 4-yl) methyl) azetidine-3-yl) methyl) methanesulfonamide,
2-(3’,6’-ジフルオロ-2’-イソプロピル-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (3', 6'-difluoro-2'-isopropyl-4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl)-[1, 1'-biphenyl] -4-yl) -1,1,1,3,3,3-hexafluoropropane-2-ol,
2-(3’,5’-ジフルオロ-2’-イソプロピル-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (3', 5'-difluoro-2'-isopropyl-4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl)-[1, 1'-biphenyl] -4-yl) -1,1,1,3,3,3-hexafluoropropane-2-ol,
6-((4’-(1,1,1,3,3,3-ヘキサフルオロ-2-ヒドロキシプロパン-2-イル)-2-イソプロピル-2’-メチル-[1,1’-ビフェニル]-4-イル)メチル)-2-チア-6-アザスピロ[3.4]オクタン 2,2-ジオキシド、 6-((4'-(1,1,1,3,3,3-hexafluoro-2-hydroxypropane-2-yl) -2-isopropyl-2'-methyl- [1,1'-biphenyl] -4-yl) Methyl) -2-thia-6-azaspiro [3.4] octane 2,2-dioxide,
6-((4’-(1,1,1,3,3,3-ヘキサフルオロ-2-ヒドロキシプロパン-2-イル)-2-イソプロピル-2’-メチル-[1,1’-ビフェニル]-4-イル)メチル)-2-チア-6-アザスピロ[3.3]ヘプタン 2,2-ジオキシド、 6-((4'-(1,1,1,3,3,3-hexafluoro-2-hydroxypropane-2-yl) -2-isopropyl-2'-methyl- [1,1'-biphenyl] -4-yl) Methyl) -2-thia-6-azaspiro [3.3] heptane 2,2-dioxide,
2-(2’-エチル-4’-((6-(メチルスルホニル)-2-アザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2'-Ethyl-4'-((6- (Methylsulfonyl) -2-azaspiro [3.3] heptane-2-yl) methyl)-[1,1'-biphenyl] -4-yl) -1,1,1,3,3,3-hexafluoropropane-2-ol,
2-(2’-(sec-ブチル)-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2'-(sec-butyl) -4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl)-[1,1'-biphenyl) ] -4-yl) -1,1,1,3,3,3-hexafluoropropane-2-ol,
2-(2’,3’-ジフルオロ-6’-イソプロピル-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2', 3'-difluoro-6'-isopropyl-4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl)-[1, 1'-biphenyl] -4-yl) -1,1,1,3,3,3-hexafluoropropane-2-ol,
1,1,1,3,3,3-ヘキサフルオロ-2-(2’-フルオロ-6’-イソプロピル-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)プロパン-2-オール、 1,1,1,3,3,3-hexafluoro-2- (2'-fluoro-6'-isopropyl-4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3]] Heptane-2-yl) Methyl)-[1,1'-biphenyl] -4-yl) Propane-2-ol,
6-((2-エチル-4’-(1,1,1,3,3,3-ヘキサフルオロ-2-ヒドロキシプロパン-2-イル)-2’-メチル-[1,1’-ビフェニル]-4-イル)メチル)-2-チア-6-アザスピロ[3.4]オクタン 2,2-ジオキシド、 6-((2-Ethyl-4'-(1,1,1,3,3,3-hexafluoro-2-hydroxypropane-2-yl) -2'-methyl- [1,1'-biphenyl]] -4-yl) Methyl) -2-thia-6-azaspiro [3.4] octane 2,2-dioxide,
6-((2-エチル-4’-(1,1,1,3,3,3-ヘキサフルオロ-2-ヒドロキシプロパン-2-イル)-[1,1’-ビフェニル]-4-イル)メチル)-2-チア-6-アザスピロ[3.4]オクタン 2,2-ジオキシド、 6-((2-Ethyl-4'-(1,1,1,3,3,3-hexafluoro-2-hydroxypropane-2-yl)-[1,1'-biphenyl] -4-yl)) Methyl) -2-thia-6-azaspiro [3.4] octane 2,2-dioxide,
6-((2-エチル-4’-(1,1,1,3,3,3-ヘキサフルオロ-2-ヒドロキシプロパン-2-イル)-2’-メチル-[1,1’-ビフェニル]-4-イル)メチル)-2-チア-6-アザスピロ[3.3]ヘプタン 2,2-ジオキシド、 6-((2-Ethyl-4'-(1,1,1,3,3,3-hexafluoro-2-hydroxypropane-2-yl) -2'-methyl- [1,1'-biphenyl]] -4-yl) Methyl) -2-thia-6-azaspiro [3.3] heptane 2,2-dioxide,
2-(2’-エチル-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.5]ノナン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2'-Ethyl-4'-((6- (Methylsulfonyl) -2,6-diazaspiro [3.5] nonane-2-yl) methyl)-[1,1'-biphenyl] -4- Il) -1,1,1,3,3,3-hexafluoropropane-2-ol,
2-(2’-エチル-4’-((2-(メチルスルホニル)-2,6-ジアザスピロ[3.5]ノナン-6-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2'-Ethyl-4'-((2- (Methylsulfonyl) -2,6-diazaspiro [3.5] nonane-6-yl) methyl)-[1,1'-biphenyl] -4- Il) -1,1,1,3,3,3-hexafluoropropane-2-ol,
2-(2’-エチル-4’-((6-(イソブチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2'-Ethyl-4'-((6- (isobutylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl)-[1,1'-biphenyl] -4- Il) -1,1,1,3,3,3-hexafluoropropane-2-ol,
2-(2’-エチル-4’-((6-(プロピルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2'-Ethyl-4'-((6- (propylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl)-[1,1'-biphenyl] -4- Il) -1,1,1,3,3,3-hexafluoropropane-2-ol,
2-(2’-エチル-4’-((6-(エチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2'-Ethyl-4'-((6- (ethylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl)-[1,1'-biphenyl] -4- Ill) -1,1,1,3,3,3-hexafluoropropane-2-ol,
2-((2-エチル-4’-(1,1,1,3,3,3-ヘキサフルオロ-2-ヒドロキシプロパン-2-イル)-[1,1’-ビフェニル]-4-イル)メチル)-7-チア-2-アザスピロ[3.5]ノナン 7,7-ジオキシド、 2-((2-Ethyl-4'-(1,1,1,3,3,3-hexafluoro-2-hydroxypropane-2-yl)-[1,1'-biphenyl] -4-yl)) Methyl) -7-thia-2-azaspiro [3.5] nonane 7,7-dioxide,
2-(2’-(tert-ブチル)-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2'-(tert-butyl) -4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl)-[1,1'-biphenyl) ] -4-yl) -1,1,1,3,3,3-hexafluoropropane-2-ol,
2-((2-エチル-4’-(1,1,1,3,3,3-ヘキサフルオロ-2-ヒドロキシプロパン-2-イル)-[1,1’-ビフェニル]-4-イル)メチル)-6-チア-2-アザスピロ[3.4]オクタン 6,6-ジオキシド、 2-((2-Ethyl-4'-(1,1,1,3,3,3-hexafluoro-2-hydroxypropane-2-yl)-[1,1'-biphenyl] -4-yl)) Methyl) -6-thia-2-azaspiro [3.4] octane 6,6-dioxide,
2-((2-エチル-4’-(1,1,1,3,3,3-ヘキサフルオロ-2-ヒドロキシプロパン-2-イル)-[1,1’-ビフェニル]-4-イル)メチル)-6-チア-2-アザスピロ[3.4]オクタン 6-オキシド、 2-((2-Ethyl-4'-(1,1,1,3,3,3-hexafluoro-2-hydroxypropane-2-yl)-[1,1'-biphenyl] -4-yl)) Methyl) -6-thia-2-azaspiro [3.4] octane 6-oxide,
6-((2-エチル-4’-(1,1,1,3,3,3-ヘキサフルオロ-2-ヒドロキシプロパン-2-イル)-[1,1’-ビフェニル]-4-イル)メチル)-2-チア-6-アザスピロ[3.3]ヘプタン 2,2-ジオキシド、 6-((2-Ethyl-4'-(1,1,1,3,3,3-hexafluoro-2-hydroxypropane-2-yl)-[1,1'-biphenyl] -4-yl)) Methyl) -2-thia-6-azaspiro [3.3] heptane 2,2-dioxide,
6-((2-エチル-4’-(1,1,1,3,3,3-ヘキサフルオロ-2-ヒドロキシプロパン-2-イル)-[1,1’-ビフェニル]-4-イル)メチル)-2-チア-6-アザスピロ[3.3]ヘプタン 2-オキシド、 6-((2-Ethyl-4'-(1,1,1,3,3,3-hexafluoro-2-hydroxypropane-2-yl)-[1,1'-biphenyl] -4-yl)) Methyl) -2-thia-6-azaspiro [3.3] heptane 2-oxide,
2-(4’-((2-チア-6-アザスピロ[3.3]ヘプタン-6-イル)メチル)-2’-エチル-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (4'-((2-Chia-6-azaspiro [3.3] heptane-6-yl) methyl) -2'-ethyl- [1,1'-biphenyl] -4-yl) -1, 1,1,3,3,3-hexafluoropropane-2-ol,
2-(2’-エチル-4’-((2-(メチルスルホニル)-2,6-ジアザスピロ[3.4]オクタン-6-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2'-Ethyl-4'-((2- (Methylsulfonyl) -2,6-diazaspiro [3.4] octane-6-yl) methyl)-[1,1'-biphenyl] -4- Il) -1,1,1,3,3,3-hexafluoropropane-2-ol,
2-(2’-エチル-4’-((7-(メチルスルホニル)-2,7-ジアザスピロ[4.4]ノナン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2'-Ethyl-4'-((7- (methylsulfonyl) -2,7-diazaspiro [4.4] nonane-2-yl) methyl)-[1,1'-biphenyl] -4- Il) -1,1,1,3,3,3-hexafluoropropane-2-ol,
2-(2’-エチル-4’-((7-(メチルスルホニル)-2,7-ジアザスピロ[3.5]ノナン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2'-Ethyl-4'-((7- (methylsulfonyl) -2,7-diazaspiro [3.5] nonane-2-yl) methyl)-[1,1'-biphenyl] -4- Il) -1,1,1,3,3,3-hexafluoropropane-2-ol,
2-(2’-エチル-4’-((2-(メチルスルホニル)-2,7-ジアザスピロ[3.5]ノナン-7-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2'-Ethyl-4'-((2- (Methylsulfonyl) -2,7-diazaspiro [3.5] nonane-7-yl) methyl)-[1,1'-biphenyl] -4- Il) -1,1,1,3,3,3-hexafluoropropane-2-ol,
2-(2’-エチル-2-フルオロ-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2'-Ethyl-2-fluoro-4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl)-[1,1'-biphenyl) ] -4-yl) -1,1,1,3,3,3-hexafluoropropane-2-ol,
2-(2’-エチル-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.4]オクタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2'-Ethyl-4'-((6- (Methylsulfonyl) -2,6-diazaspiro [3.4] octane-2-yl) methyl)-[1,1'-biphenyl] -4- Il) -1,1,1,3,3,3-hexafluoropropane-2-ol,
2-(2’-エチル-6’-フルオロ-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2'-ethyl-6'-fluoro-4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl)-[1,1'- Biphenyl] -4-yl) -1,1,1,3,3,3-hexafluoropropane-2-ol,
2-(2’-エチル-5’-フルオロ-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2'-ethyl-5'-fluoro-4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl)-[1,1'- Biphenyl] -4-yl) -1,1,1,3,3,3-hexafluoropropane-2-ol,
2-(2’-エチル-3’-フルオロ-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2'-ethyl-3'-fluoro-4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl)-[1,1'- Biphenyl] -4-yl) -1,1,1,3,3,3-hexafluoropropane-2-ol,
tert-ブチル2-((2-エチル-4’-(1,1,1,3,3,3-ヘキサフルオロ-2-ヒドロキシプロパン-2-イル)-[1,1’-ビフェニル]-4-イル)メチル)-2,6-ジアザスピロ[3.4]オクタン-6-カルボキシレート、 tert-Butyl 2-((2-ethyl-4'-(1,1,1,3,3,3-hexafluoro-2-hydroxypropane-2-yl)-[1,1'-biphenyl] -4 -Il) Methyl) -2,6-diazaspiro [3.4] octane-6-carboxylate,
2-(2’-エチル-2-メチル-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2'-Ethyl-2-methyl-4'-((6- (Methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl)-[1,1'-biphenyl) ] -4-yl) -1,1,1,3,3,3-hexafluoropropane-2-ol,
メチル6-((2-エチル-4’-(1,1,1,3,3,3-ヘキサフルオロ-2-ヒドロキシプロパン-2-イル)-[1,1’-ビフェニル]-4-イル)メチル)-2,6-ジアザスピロ[3.3]ヘプタン-2-カルボキシレート、 Methyl 6-((2-ethyl-4'-(1,1,1,3,3,3-hexafluoro-2-hydroxypropane-2-yl)-[1,1'-biphenyl] -4-yl)-[1,1'-biphenyl] -4-yl ) Methyl) -2,6-diazaspiro [3.3] heptane-2-carboxylate,
2-(4’-((6-(シクロプロピルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-2’-エチル-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2-(2’-シクロプロピル-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (4'-((6- (Cyclopropylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl) -2'-ethyl- [1,1'-biphenyl] -4 -Il) -1,1,1,3,3,3-hexafluoropropane-2-ol, 2- (2'-cyclopropyl-4'-((6- (methylsulfonyl) -2,6-diazaspiro) [3.3] Heptan-2-yl) Methyl)-[1,1'-biphenyl] -4-yl) -1,1,1,3,3,3-hexafluoropropane-2-ol,
1,1,1,3,3,3-ヘキサフルオロ-2-(2’-イソプロピル-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)プロパン-2-オール、 1,1,1,3,3,3-hexafluoro-2- (2'-isopropyl-4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl] ) Methyl)-[1,1'-biphenyl] -4-yl) Propane-2-ol,
tert-ブチル6-((2-エチル-4’-(1,1,1,3,3,3-ヘキサフルオロ-2-ヒドロキシプロパン-2-イル)-[1,1’-ビフェニル]-4-イル)メチル)-2,6-ジアザスピロ[3.3]ヘプタン-2-カルボキシレート、 tert-butyl 6-((2-ethyl-4'-(1,1,1,3,3,3-hexafluoro-2-hydroxypropane-2-yl)-[1,1'-biphenyl] -4 -Il) Methyl) -2,6-diazaspiro [3.3] heptane-2-carboxylate,
1,1,1,3,3,3-ヘキサフルオロ-2-(4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-2’-(プロプ-1-エン-2-イル)-[1,1’-ビフェニル]-4-イル)プロパン-2-オール、 1,1,1,3,3,3-hexafluoro-2- (4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl) -2 '-(Prop-1-en-2-yl)-[1,1'-biphenyl] -4-yl) Propane-2-ol,
2-(2’-ブロモ-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2'-bromo-4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl)-[1,1'-biphenyl] -4- Il) -1,1,1,3,3,3-hexafluoropropane-2-ol,
1,1,1,3,3,3-ヘキサフルオロ-2-(4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-2’-(トリフルオロメチル)-[1,1’-ビフェニル]-4-イル)プロパン-2-オール、 1,1,1,3,3,3-hexafluoro-2- (4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl) -2 '-(Trifluoromethyl)-[1,1'-biphenyl] -4-yl) Propane-2-ol,
2-(2’-クロロ-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2'-Chloro-4'-((6- (Methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl)-[1,1'-biphenyl] -4- Il) -1,1,1,3,3,3-hexafluoropropane-2-ol,
1-(6-((2-エチル-4’-(1,1,1,3,3,3-ヘキサフルオロ-2-ヒドロキシプロパン-2-イル)-[1,1’-ビフェニル]-4-イル)メチル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)エタン-1-オン、 1-(6-((2-Ethyl-4'-(1,1,1,3,3,3-hexafluoro-2-hydroxypropane-2-yl)-[1,1'-biphenyl] -4 -Il) Methyl) -2,6-diazaspiro [3.3] heptane-2-yl) ethane-1-one,
2-(2’-エチル-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2'-Ethyl-4'-((6- (Methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl)-[1,1'-biphenyl] -4- Il) -1,1,1,3,3,3-hexafluoropropane-2-ol,
1-(6-((4’-(1,1,1,3,3,3-ヘキサフルオロ-2-ヒドロキシプロパン-2-イル)-2-メチル-[1,1’-ビフェニル]-4-イル)メチル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)エタン-1-オン、 1-(6-((4'-(1,1,1,3,3,3-hexafluoro-2-hydroxypropane-2-yl) -2-methyl- [1,1'-biphenyl] -4 -Il) Methyl) -2,6-diazaspiro [3.3] heptane-2-yl) ethane-1-on,
1,1,1,3,3,3-ヘキサフルオロ-2-(2’-メチル-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)プロパン-2-オール、 1,1,1,3,3,3-hexafluoro-2- (2'-methyl-4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl] ) Methyl)-[1,1'-biphenyl] -4-yl) Propane-2-ol,
1,1,1,3,3,3-ヘキサフルオロ-2-(2’-メチル-4’-((6-(ピリジン-4-イルメチル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)プロパン-2-オール、 1,1,1,3,3,3-hexafluoro-2- (2'-methyl-4'-((6- (pyridin-4-ylmethyl) -2,6-diazaspiro [3.3] heptane-" 2-Il) Methyl)-[1,1'-biphenyl] -4-yl) Propane-2-ol,
2-(4-(3-エチル-5-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)ピリジン-2-イル)フェニル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (4- (3-Ethyl-5-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl) pyridin-2-yl) phenyl) -1, 1,1,3,3,3-hexafluoropropane-2-ol,
7-((2-エチル-4’-(1,1,1,3,3,3-ヘキサフルオロ-2-ヒドロキシプロパン-2-イル)-[1,1’-ビフェニル]-4-イル)メチル)-2,7-ジアザスピロ[4.4]ノナン-1-オン、 7-((2-Ethyl-4'-(1,1,1,3,3,3-hexafluoro-2-hydroxypropane-2-yl)-[1,1'-biphenyl] -4-yl)) Methyl) -2,7-diazaspiro [4.4] nonane-1-one,
7-((2-エチル-4’-(1,1,1,3,3,3-ヘキサフルオロ-2-ヒドロキシプロパン-2-イル)-[1,1’-ビフェニル]-4-イル)メチル)-2,7-ジアザスピロ[4.4]ノナン-3-オン、 7-((2-Ethyl-4'-(1,1,1,3,3,3-hexafluoro-2-hydroxypropane-2-yl)-[1,1'-biphenyl] -4-yl)) Methyl) -2,7-diazaspiro [4.4] nonane-3-one,
4’-(1,1,1,3,3,3-ヘキサフルオロ-2-ヒドロキシプロパン-2-イル)-N,N-ジメチル-4-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-2-カルボキサミド、 4'-(1,1,1,3,3,3-hexafluoro-2-hydroxypropane-2-yl) -N, N-dimethyl-4-((6- (methylsulfonyl) -2,6-yl) Diazaspiro [3.3] heptane-2-yl) methyl)-[1,1'-biphenyl] -2-carboxamide,
2-(2’-エチル-2-メトキシ-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2'-Ethyl-2-methoxy-4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl)-[1,1'-biphenyl) ] -4-yl) -1,1,1,3,3,3-hexafluoropropane-2-ol,
1,1,1,3,3,3-ヘキサフルオロ-2-(2’-メトキシ-2-メチル-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)プロパン-2-オール、 1,1,1,3,3,3-hexafluoro-2- (2'-methoxy-2-methyl-4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane] -2-Il) Methyl)-[1,1'-biphenyl] -4-yl) Propane-2-ol,
7-((2-エチル-4’-(1,1,1,3,3,3-ヘキサフルオロ-2-ヒドロキシプロパン-2-イル)-[1,1’-ビフェニル]-4-イル)メチル)-2-チア-7-アザスピロ[4.4]ノナン 2,2-ジオキシド、 7-((2-Ethyl-4'-(1,1,1,3,3,3-hexafluoro-2-hydroxypropane-2-yl)-[1,1'-biphenyl] -4-yl)) Methyl) -2-thia-7-azaspiro [4.4] nonane 2,2-dioxide,
2-(5-(2-エチル-4-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)フェニル)ピリジン-2-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (5- (2-Ethyl-4-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl) phenyl) pyridin-2-yl) -1, 1,1,3,3,3-hexafluoropropane-2-ol,
2-(4-(4-エチル-6-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)ピリジン-3-イル)フェニル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (4- (4-Ethyl-6-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl) pyridin-3-yl) phenyl) -1, 1,1,3,3,3-hexafluoropropane-2-ol,
4’-(1,1,1,3,3,3-ヘキサフルオロ-2-ヒドロキシプロパン-2-イル)-4-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-3-オール、 4'-(1,1,1,3,3,3-hexafluoro-2-hydroxypropane-2-yl) -4-((6- (methylsulfonyl) -2,6-diazaspiro [3.3]] Heptane-2-yl) methyl)-[1,1'-biphenyl] -3-ol,
2-(2’-シクロプロピル-3’,6’-ジフルオロ-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2'-Cyclopropyl-3', 6'-difluoro-4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl)-[1 , 1'-biphenyl] -4-yl) -1,1,1,3,3,3-hexafluoropropane-2-ol,
2-(2’-シクロプロピル-2,3’,6’-トリフルオロ-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2'-Cyclopropyl-2,3', 6'-trifluoro-4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl) -[1,1'-biphenyl] -4-yl) -1,1,1,3,3,3-hexafluoropropane-2-ol,
2-(2-クロロ-2’-シクロプロピル-3’,6’-ジフルオロ-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2-Chloro-2'-cyclopropyl-3', 6'-difluoro-4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl) )-[1,1'-biphenyl] -4-yl) -1,1,1,3,3,3-hexafluoropropane-2-ol,
1,1,1,3,3,3-ヘキサフルオロ-2-(2,3’,6’-トリフルオロ-2’-イソプロピル-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)プロパン-2-オール、 1,1,1,3,3,3-hexafluoro-2- (2,3', 6'-trifluoro-2'-isopropyl-4'-((6- (methylsulfonyl) -2,6-" Diazaspiro [3.3] heptane-2-yl) methyl)-[1,1'-biphenyl] -4-yl) propane-2-ol,
2-(2’-シクロプロピル-2-エチル-3’,6’-ジフルオロ-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2'-Cyclopropyl-2-ethyl-3', 6'-difluoro-4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl) )-[1,1'-biphenyl] -4-yl) -1,1,1,3,3,3-hexafluoropropane-2-ol,
2-(2’-シクロプロピル-3’,6’-ジフルオロ-2-メチル-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2'-Cyclopropyl-3', 6'-difluoro-2-methyl-4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl) )-[1,1'-biphenyl] -4-yl) -1,1,1,3,3,3-hexafluoropropane-2-ol,
2-(2-クロロ-5’-フルオロ-2’-イソプロピル-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2-Chloro-5'-fluoro-2'-isopropyl-4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl)-[1 , 1'-biphenyl] -4-yl) -1,1,1,3,3,3-hexafluoropropane-2-ol,
1,1,1,3,3,3-ヘキサフルオロ-2-(5’-フルオロ-2’-イソプロピル-2-メチル-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)プロパン-2-オール、 1,1,1,3,3,3-hexafluoro-2- (5'-fluoro-2'-isopropyl-2-methyl-4'-((6- (methylsulfonyl) -2,6-diazaspiro [ 3.3] Heptane-2-yl) Methyl)-[1,1'-biphenyl] -4-yl) Propane-2-ol,
2-(2,5’-ジフルオロ-2’-イソプロピル-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2,5'-difluoro-2'-isopropyl-4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl)-[1,1 '-Biphenyl] -4-yl) -1,1,1,3,3,3-hexafluoropropane-2-ol,
2-(2-クロロ-3’,6’-ジフルオロ-2’-イソプロピル-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2-Chloro-3', 6'-difluoro-2'-isopropyl-4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl) -[1,1'-biphenyl] -4-yl) -1,1,1,3,3,3-hexafluoropropane-2-ol,
2-(2-エチル-3’,6’-ジフルオロ-2’-イソプロピル-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2-Ethyl-3', 6'-difluoro-2'-isopropyl-4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl) -[1,1'-biphenyl] -4-yl) -1,1,1,3,3,3-hexafluoropropane-2-ol,
2-(3’,6’-ジフルオロ-2’-イソプロピル-2-メチル-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (3', 6'-difluoro-2'-isopropyl-2-methyl-4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl) -[1,1'-biphenyl] -4-yl) -1,1,1,3,3,3-hexafluoropropane-2-ol,
2-(2’-エチル-3’,6’-ジフルオロ-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2'-ethyl-3', 6'-difluoro-4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl)-[1, 1'-biphenyl] -4-yl) -1,1,1,3,3,3-hexafluoropropane-2-ol,
2-(2,2’-ジエチル-3’,6’-ジフルオロ-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2,2'-diethyl-3', 6'-difluoro-4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl)-[ 1,1'-biphenyl] -4-yl) -1,1,1,3,3,3-hexafluoropropane-2-ol,
2-(2-クロロ-2’-エチル-3’,6’-ジフルオロ-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2-Chloro-2'-ethyl-3', 6'-difluoro-4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl) -[1,1'-biphenyl] -4-yl) -1,1,1,3,3,3-hexafluoropropane-2-ol,
2-(2-クロロ-2’-エチル-5’-フルオロ-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2-Chloro-2'-ethyl-5'-fluoro-4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl)-[1 , 1'-biphenyl] -4-yl) -1,1,1,3,3,3-hexafluoropropane-2-ol,
2-(2’-エチル-2,5’-ジフルオロ-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2'-Ethyl-2,5'-difluoro-4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl)-[1,1 '-Biphenyl] -4-yl) -1,1,1,3,3,3-hexafluoropropane-2-ol,
1,1,1,3,3,3-ヘキサフルオロ-2-(5’-フルオロ-2’-イソプロピル-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)プロパン-2-オール、 1,1,1,3,3,3-hexafluoro-2- (5'-fluoro-2'-isopropyl-4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3]] Heptane-2-yl) Methyl)-[1,1'-biphenyl] -4-yl) Propane-2-ol,
2-(2,2’-ジエチル-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2,2'-diethyl-4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl)-[1,1'-biphenyl]- 4-Il) -1,1,1,3,3,3-hexafluoropropane-2-ol,
2-(2’-エチル-2,3’,6’-トリフルオロ-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2'-ethyl-2,3', 6'-trifluoro-4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl)- [1,1'-biphenyl] -4-yl) -1,1,1,3,3,3-hexafluoropropane-2-ol,
2-(2-エチル-2’-メチル-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2-Ethyl-2'-methyl-4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl)-[1,1'-biphenyl) ] -4-yl) -1,1,1,3,3,3-hexafluoropropane-2-ol,
2-(2-クロロ-2’-エチル-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2-Chloro-2'-ethyl-4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl)-[1,1'-biphenyl) ] -4-yl) -1,1,1,3,3,3-hexafluoropropane-2-ol,
2-(3’,6’-ジフルオロ-2’-イソプロピル-4’-((2-(メチルスルホニル)-2,6-ジアザスピロ[3.4]オクタン-6-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (3', 6'-difluoro-2'-isopropyl-4'-((2- (methylsulfonyl) -2,6-diazaspiro [3.4] octane-6-yl) methyl)-[1, 1'-biphenyl] -4-yl) -1,1,1,3,3,3-hexafluoropropane-2-ol,
2-(4-(2-エチル-6-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)ピリジン-3-イル)-3-メチルフェニル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (4- (2-Ethyl-6-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl) pyridin-3-yl) -3-methylphenyl )-1,1,1,3,3,3-hexafluoropropane-2-ol,
2-(2’-エチル-3’,6’-ジフルオロ-2-メチル-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2'-ethyl-3', 6'-difluoro-2-methyl-4'-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl) -[1,1'-biphenyl] -4-yl) -1,1,1,3,3,3-hexafluoropropane-2-ol,
2’-エチル-4-(1,1,1,3,3,3-ヘキサフルオロ-2-ヒドロキシプロパン-2-イル)-4’-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)-[1,1’-ビフェニル]-2-カルボニトリル、 2'-Ethyl-4- (1,1,1,3,3,3-hexafluoro-2-hydroxypropane-2-yl) -4'-((6- (methylsulfonyl) -2,6-diazaspiro) [3.3] Heptane-2-yl) Methyl)-[1,1'-biphenyl] -2-carbonitrile,
2-(4-(4-エチル-6-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)ピリジン-3-イル)-3-メチルフェニル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (4- (4-Ethyl-6-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl) pyridin-3-yl) -3-methylphenyl )-1,1,1,3,3,3-hexafluoropropane-2-ol,
2-(6-(2-エチル-4-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)フェニル)ピリジン-3-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (6-(2-Ethyl-4-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl) phenyl) pyridin-3-yl) -1, 1,1,3,3,3-hexafluoropropane-2-ol,
2-(4-(3-エチル-5-((6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)メチル)ピリジン-2-イル)-3-メチルフェニル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (4- (3-Ethyl-5-((6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl) methyl) pyridin-2-yl) -3-methylphenyl) )-1,1,1,3,3,3-hexafluoropropane-2-ol,
1,1,1,3,3,3-ヘキサフルオロ-2-(3-メチル-4-(6-(6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)ピリジン-2-イル)フェニル)プロパン-2-オール、および、 1,1,1,3,3,3-hexafluoro-2- (3-methyl-4- (6-(6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl] ) Pyridine-2-yl) Phenyl) Propane-2-ol, and
2-(2,2’-ジメチル-3’-(6-(メチルスルホニル)-2,6-ジアザスピロ[3.3]ヘプタン-2-イル)-[1,1’-ビフェニル]-4-イル)-1,1,1,3,3,3-ヘキサフルオロプロパン-2-オール、 2- (2,2'-dimethyl-3'-(6- (methylsulfonyl) -2,6-diazaspiro [3.3] heptane-2-yl)-[1,1'-biphenyl] -4-yl) )-1,1,1,3,3,3-hexafluoropropane-2-ol,
から選択される、請求項1に記載の化合物、あるいはその薬学的に許容可能な塩、溶媒和物、または立体異性体。The compound according to claim 1, or a pharmaceutically acceptable salt, solvate, or stereoisomer thereof, which is selected from the above.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862641949P | 2018-03-12 | 2018-03-12 | |
US62/641,949 | 2018-03-12 | ||
PCT/US2019/021671 WO2019177997A1 (en) | 2018-03-12 | 2019-03-11 | Spirocyclic ror-gamma modulators |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2021517565A JP2021517565A (en) | 2021-07-26 |
JPWO2019177997A5 true JPWO2019177997A5 (en) | 2022-03-18 |
Family
ID=67906868
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020547384A Pending JP2021517565A (en) | 2018-03-12 | 2019-03-11 | Spiro cyclic ROR-γ modulator |
Country Status (11)
Country | Link |
---|---|
US (2) | US11242350B2 (en) |
EP (1) | EP3765020A4 (en) |
JP (1) | JP2021517565A (en) |
KR (1) | KR20210060367A (en) |
CN (1) | CN112118841A (en) |
AU (1) | AU2019234541A1 (en) |
BR (1) | BR112020018718A2 (en) |
CA (1) | CA3093695A1 (en) |
EA (1) | EA202092051A1 (en) |
MX (1) | MX2020009459A (en) |
WO (1) | WO2019177997A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210060367A (en) | 2018-03-12 | 2021-05-26 | 에스칼리에 바이오사이언시스, 비브이 | Spirocyclic ROR-gamma modulator |
WO2019177996A1 (en) | 2018-03-12 | 2019-09-19 | Escalier Biosciences B.V. | Bicyclic ror-gamma modulators |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6432957B1 (en) | 2001-06-29 | 2002-08-13 | Kowa Co., Ltd. | Piperazine derivative |
AU2003280558A1 (en) | 2002-10-11 | 2004-05-04 | Kowa Co., Ltd. | Method for treatment of cancer |
TW201006816A (en) * | 2008-05-15 | 2010-02-16 | Organon Nv | Hexafluoroisopropanol derivatives |
WO2011115892A1 (en) | 2010-03-15 | 2011-09-22 | Griffin Patrick R | Modulators of the retinoic acid receptor-related orphan receptors |
US9586928B2 (en) | 2011-05-16 | 2017-03-07 | The Scripps Research Institute | Modulators of the nuclear hormone receptor ROR |
AR092348A1 (en) | 2012-07-11 | 2015-04-15 | Hoffmann La Roche | ARIL-SULTAMO DERIVATIVES AS RORc MODULATORS |
WO2015035278A1 (en) | 2013-09-09 | 2015-03-12 | Bristol-Myers Squibb Company | RORγ MODULATORS |
WO2016014910A1 (en) | 2014-07-25 | 2016-01-28 | Innov17 Llc | Sulfonamide retinoic acid receptor-related orphan receptor modulators and uses thereof |
JOP20200117A1 (en) | 2014-10-30 | 2017-06-16 | Janssen Pharmaceutica Nv | TRIFLUOROMETHYL ALCOHOLS AS MODULATORS OF ROR?t |
BR112017008852A2 (en) | 2014-10-30 | 2018-01-16 | Janssen Pharmaceutica N.V. | amide substituted thiazoles as roryt modulators |
US9861618B2 (en) | 2014-10-30 | 2018-01-09 | Janssen Pharmaceutica Nv | Thiazoles as modulators of RORγt |
WO2017127442A1 (en) | 2016-01-18 | 2017-07-27 | The Regents Of The University Of California | Methods for treating cancer with rorgamma inhibitors |
TWI691486B (en) | 2016-01-29 | 2020-04-21 | 日商東麗股份有限公司 | Cyclic amine derivatives and pharmaceutical use thereof |
TW201803869A (en) | 2016-04-27 | 2018-02-01 | 健生藥品公司 | 6-aminopyridin-3-yl thiazoles as modulators of ROR[gamma]t |
JP7027437B2 (en) | 2016-10-27 | 2022-03-01 | エスカリア バイオサイエンシーズ,ビーブイ | ROR-γ modulator |
WO2019177996A1 (en) | 2018-03-12 | 2019-09-19 | Escalier Biosciences B.V. | Bicyclic ror-gamma modulators |
KR20210060367A (en) | 2018-03-12 | 2021-05-26 | 에스칼리에 바이오사이언시스, 비브이 | Spirocyclic ROR-gamma modulator |
-
2019
- 2019-03-11 KR KR1020207028944A patent/KR20210060367A/en not_active Application Discontinuation
- 2019-03-11 JP JP2020547384A patent/JP2021517565A/en active Pending
- 2019-03-11 BR BR112020018718-6A patent/BR112020018718A2/en not_active IP Right Cessation
- 2019-03-11 CN CN201980032074.4A patent/CN112118841A/en active Pending
- 2019-03-11 WO PCT/US2019/021671 patent/WO2019177997A1/en unknown
- 2019-03-11 MX MX2020009459A patent/MX2020009459A/en unknown
- 2019-03-11 US US16/979,833 patent/US11242350B2/en active Active
- 2019-03-11 EA EA202092051A patent/EA202092051A1/en unknown
- 2019-03-11 AU AU2019234541A patent/AU2019234541A1/en not_active Abandoned
- 2019-03-11 EP EP19768035.8A patent/EP3765020A4/en not_active Withdrawn
- 2019-03-11 CA CA3093695A patent/CA3093695A1/en active Pending
-
2021
- 2021-12-15 US US17/552,206 patent/US20220106323A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11229636B2 (en) | Substituted tetrahydroquinolinone compounds as ROR gamma modulators | |
AU2016371600B2 (en) | Biaryl monobactam compounds and methods of use thereof for the treatment of bacterial infections | |
CN105143221B (en) | Compound and its pharmaceutical composition for treating inflammatory disorder | |
JP2018520161A5 (en) | ||
RU2688938C2 (en) | PYRROLO[3,2-B]PYRIDINE DERIVATIVE USEFUL AS A MUSCARINE ACETYLCHOLINE RECEPTOR MODULATOR (mAChR)M1 (mAChR M1) | |
MX2014013554A (en) | BICYCLIC SULFONE COMPOUNDS FOR INHIBITION OF RORy ACTIVITY AND THE TREATMENT OF DISEASE. | |
EA026724B1 (en) | Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation | |
CN105530932A (en) | Primary carboxamides as BIK inhibitors | |
JP2013523884A5 (en) | ||
JP2019536785A5 (en) | ||
EA018721B1 (en) | Hedgehog pathway modulators | |
EA028122B1 (en) | 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh | |
AU2009246626A1 (en) | Oxazolobenzimidazole derivatives | |
JP6709792B2 (en) | Therapeutic compounds and uses thereof | |
JP2006511552A5 (en) | ||
RU2013103079A (en) | HETEROCYCLIC COMPOUNDS OF BENZODIOXOL OR BENZODIOXEPIN AS PHOSPHODYESTERASE INHIBITORS | |
JP2016514711A (en) | Acyclic cyanoethylpyrazolopyridone as a Janus kinase inhibitor | |
WO2018100070A1 (en) | Bicyclic amide compounds and methods of use thereof | |
WO2022118210A1 (en) | Substituted thiadiazolyl derivatives as dna polymerase theta inhibitors | |
RU2013154733A (en) | DERIVATIVES OF BENZOCYCLOHEPTENE ACID ACID | |
JPWO2019177997A5 (en) | ||
WO2016177690A1 (en) | Tricyclic piperidine compounds | |
JP2007507464A5 (en) | ||
CN112292124A (en) | Bicyclic ROR-gamma modulators | |
JP2015528435A5 (en) |